Driving Pharmaceutical Innovation Forward

Research & development focused on advancing global healthcare

Strategic Allocation

Molecular
Distribution

Our 70/30 split ensures a continuous flow of innovation while maintaining a robust portfolio of market-ready pharmaceutical solutions.

R&D Pipeline
70%
Market Ready
30%

Innovation Engine

Our R&D focus is centered on next-generation injectable therapies and GMP-compliant molecular discovery. We invest heavily in the early stages to ensure long-term clinical success.

  • Pre-clinical Validation
  • Molecular Stability Testing
  • GMP Protocol Development

Data reflects Q3 2024 portfolio audit. All clinical phases are monitored under strict UK pharmaceutical regulatory standards.

Research Leadership

Our credentials in pharmaceutical innovation are built on decades of collective expertise and a commitment to clinical excellence.

Dr. Alistair Parker

Dr. Alistair Parker

Chief Scientific Officer

Leading global clinical trials and molecular research.

Research Mission

Our research is anchored in absolute scientific rigor, ensuring every molecule developed meets the highest global standards for safety and efficacy in injectable therapies.

Scientific Rigor

Dr. Sarah Chen

Dr. Sarah Chen

Head of R&D

Specializing in GMP-compliant formulation and delivery systems.

Scientific Contributions

Peer-Reviewed
Advanced Injectable Delivery Systems
Journal of Pharmaceutical Sciences

A comprehensive study on the stability of complex molecules in sterile environments.

Keynote
Future of GMP Manufacturing
Global Pharma Summit 2024

Keynote presentation on integrating AI into quality assurance protocols.

GMP-Certified
Enoxaparin Bioavailability Analysis
Clinical Pharmacology Review

Comparative analysis of synthetic vs. biological heparin derivatives.

Clinical Collaborations

Global Health Initiative
BioTech Research Lab
University of Clinical Excellence
PharmaLink Logistics
St. Jude Medical Center

Regulatory Notice: Parkers Pharma products including Enoxaparin and Tirzepatide are for professional medical use. GMP-compliant manufacturing ensures global quality assurance standards.

© 2024 Parkers Pharma UK. Scientific Innovation in Healthcare.

GMP Certified Facility • Quality Assurance Division